At Longwall Ventures we invest in early stage businesses that are harnessing the UK’s expertise in science R&D to address the global challenges of tomorrow.

Focusing on health, resilience and sustainability, our interests are diverse but often in areas where we have existing knowledge and interest.

Our investments to date range from life science tools to new measurement or instrumentation techniques, from space to security. We invest in companies that have the potential to disrupt an existing market or gain a material share of a new market, with a preference for B2B opportunities rather than consumer products.

Longwall’s focus is on Responsible Investment and we are committed to strengthening diversity within our team and portfolio companies.

We are signatories to the Investing in Women Code, a commitment by financial services firms to improving female entrepreneurs’ access to tools, resources and finance.

As part of this we have appointed a member of the senior leadership team to support equality in all of our interactions with entrepreneurs and provide regular data on the diversity of the businesses in which we invest, as well as reviewing our procedures to promote inclusion.